Revenue and profitability snapshot
- Revenue: None reported in QQ2 2025 (no line items provided for revenue in the period).
- EBITDA: -$202,957; Operating loss: -$202,957; No operating margin data available.
- Net income: -$170,303; EPS: -$0.0226 (diluted), based on 7,522,430 weighted-average shares.
- YoY / QoQ earnings metrics (from available data):
- Operating Income: YoY +66.44%; QoQ +25.08% (still negative)
- Net Income: YoY +56.80%; QoQ -9.97% (negative baseline persists)
- EPS (diluted): YoY +51.40%; QoQ -9.71%
Liquidity and cash flows
- Net cash from operating activities: -$109,142
- Free cash flow: -$109,142
- Net cash provided by financing activities: $168,895
- Net cash used in investing activities: -$60,000
- Net change in cash: -$247
- Cash at beginning of period: $247; Cash at end: not disclosed (null)
Balance sheet health
- Total assets: $11,849,083
- Total liabilities: $15,239,879
- Total stockholders’ equity: -$3,390,796
- Short-term debt: $4,186,927
- Total debt: $4,186,927
- Current assets: $47,805; Current liabilities: $7,065,563 (current ratio ~0.0068; quick ratio ~0.0068)
- Major asset composition: OtherNonCurrentAssets $11,801,278; receivables $10,000; cash and cash equivalents not disclosed (null)
Valuation and implied multiples
- Price-to-book: -24.09 (negative due to negative equity)
- Price-to-earnings: -119.92 (negative due to loss)
- Revenue multiple and cash flow multiples are not meaningful given the shell status and lack of operating revenue
Notes on quarterly cadence
- The four-quarter data show a consistent pattern of minimal operating activity with a heavy reliance on financing to fund ongoing shell operations. The QQ2 2025 quarter echoes this pattern with a modest G&A expense of $152,957 and a non-operating gain/other income of $60,459 helping to offset some costs, but not translating into revenue or profitability.